Search results
Catalyst's New CEO Has Big Ideas For The Small Biotech
Investor's Business Daily· 4 days agoCatalyst Pharmaceuticals' new Chief Executive, Richard Daly, is no stranger to working at big...
Top 4 Health Care Stocks Which Could Rescue Your Portfolio This Month - Enovis (NYSE:ENOV),...
Benzinga· 7 days agoLoading... Loading... The most oversold stocks in the health care sector presents an opportunity to...
BMS and Zai Lab’s Augtyro gains NMPA approval to treat NSCLC
Pharmaceutical Technology via Yahoo Finance· 18 hours agoZai Lab has announced that its New Drug Application (NDA) for Augtyro (repotrectinib) has been...
India's Alembic Pharma posts higher Q4 profit on strong N.America sales
Reuters· 5 days agoIndian generic drugmaker Alembic Pharma reported a 17% rise in fourth-quarter profit on Thursday,...
Drugmakers in Medicare Price Talks Spent Less on R&D Than on Shareholders, Marketing, Overhead:...
The Fiscal Times via Yahoo Finance· 4 days agoEight drug companies that make the 10 medications whose prices are currently being negotiated by...
Health Care Roundup: Market Talk
The Wall Street Journal· 12 hours agoNEWSPLUS The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 1506 ET...
Cytokinetics shows hand in high stakes rivalry with BMS' Camzyos
FierceBiotech· 20 hours agoCytokinetics has set out to prove that aficamten is a threat to Bristol Myers Squibb’s $13.1 billion...
A Look at Pharma ETFs Post Q1 Earnings - Bristol-Myers Squibb (NYSE:BMY), First Trust Nasdaq...
Benzinga· 5 days agoThe first-quarter results of the healthcare sector have been unimpressive, with earnings of 78% of...
Veeva and H&E Equipment Services have been highlighted as Zacks Bull and Bear of the Day
Zacks via Yahoo Finance· 24 hours agoFor Immediate Release Chicago, IL – May 13, 2024 – Zacks Equity Research shares Veeva Systems VEEV...
Merck stopped a clinical trial for its experimental skin cancer drug after a high rate of side...
Quartz· 17 hours agoMerck announced Monday that it is pulling the plug on its phase 3 trial of an experimental...